24 HR pramipexole dihydrochloride 4.5 MG Extended Release Oral Tablet — RxCUI 901534
RxNorm drug concept · Semantic clinical drug
RxCUI 901534
Semantic clinical drug · SCD
● Current RxNorm concept 39 FDA products
46 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI901534
Official name24 HR pramipexole dihydrochloride 4.5 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspramipexole dihydrochloride 4.5 MG 24HR Extended Release Oral Tablet
FDA products mapped39
Package NDCs mapped46
Reported Medicaid activity (SDUD)732 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pramipexole: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Pramipexole is mainly used to treat Parkinson's disease — it helps manage the motor symptoms like tremor and stiffness by mimicking a brain chemical called dopamine. The immediate-...
- It can, yes — drowsiness is one of the most common side effects. But the bigger concern is something called a 'sleep attack,' where you fall asleep suddenly during everyday activit...
- Will this medication make me really drowsy?
- This is a real and important risk. Some people develop strong, hard-to-control urges while taking pramipexole — things like gambling, spending money compulsively, binge eating, or...
🕸️ Concept Web — How 24 HR pramipexole dihydrochloride 4.5 MG Extende... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR pramipexole dihydrochloride 4.5 MG Extended Release Oral Tablet
RxCUI 901534 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Pramipexole
746741IN -
Pramipexole dihydrochloride
236747PIN
-
Pramipexole
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Mirapex
218402BN
-
Mirapex
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pramipexole Extended Release Oral Tablet
901533SCDF -
Pramipexole dihydrochloride Extended Release Oral Tablet
2648067SCDFP -
Pramipexole Oral Product
1161097SCDG -
Pramipexole Pill
1161689SCDG -
Pramipexole dihydrochloride Oral Product
2661805SCDGP -
Pramipexole dihydrochloride Pill
2660634SCDGP -
Pramipexole Extended Release Oral Tablet [Mirapex]
901536SBDF -
Pramipexole dihydrochloride Extended Release Oral Tablet [Mirapex]
2658580SBDFP - +5 more in this family
-
Pramipexole Extended Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pramipexole dihydrochloride 4.5 MG
901532SCDC -
24 HR pramipexole dihydrochloride 4.5 MG Extended Release Oral Tablet [Mirapex]
901537SBD -
Pramipexole dihydrochloride 4.5 MG [Mirapex]
901535SBDC
-
Pramipexole dihydrochloride 4.5 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pramipexole dihydrochloride 4.5 MG
SCDC · 901532 -
Pramipexole Extended Release Oral Tablet
SCDF · 901533 -
Pramipexole dihydrochloride Extended Release Oral Tablet
SCDFP · 2648067 -
Pramipexole Oral Product
SCDG · 1161097 -
Pramipexole Pill
SCDG · 1161689 -
Pramipexole dihydrochloride Oral Product
SCDGP · 2661805 -
Pramipexole dihydrochloride Pill
SCDGP · 2660634
Brand-Name Concepts
-
24 HR pramipexole dihydrochloride 4.5 MG Extended Release Oral Tablet [Mirapex]
SBD · 901537 -
Pramipexole dihydrochloride 4.5 MG [Mirapex]
SBDC · 901535 -
Pramipexole Extended Release Oral Tablet [Mirapex]
SBDF · 901536 -
Pramipexole dihydrochloride Extended Release Oral Tablet [Mirapex]
SBDFP · 2658580 -
Mirapex Oral Product
SBDG · 1180460 -
Mirapex Pill
SBDG · 1180461 -
Mirapex
BN · 218402
📦 FDA Products & Package NDCs
39 products · 46 package NDCs
46 package NDCs map to RxCUI 901534 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 16714-0916-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-916-01) | Pramipexole Dihydrochloride | NorthStar RxLLC | 2019-03-06 |
| 16714-0917-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-917-01) | Pramipexole Dihydrochloride | NorthStar RxLLC | 2019-03-06 |
| 16714-0918-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-918-01) | Pramipexole Dihydrochloride | NorthStar RxLLC | 2019-03-06 |
| 16714-0919-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-919-01) | Pramipexole Dihydrochloride | NorthStar RxLLC | 2019-03-06 |
| 16714-0920-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-920-01) | Pramipexole Dihydrochloride | NorthStar RxLLC | 2019-03-06 |
| 16714-0922-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-922-01) | Pramipexole Dihydrochloride | NorthStar RxLLC | 2019-03-06 |
| 33342-0208-07 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-208-07) | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0208-12 | 10 BLISTER PACK in 1 CARTON (33342-208-12) / 10 TABLET, EXT... | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0209-07 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-209-07) | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0209-12 | 10 BLISTER PACK in 1 CARTON (33342-209-12) / 10 TABLET, EXT... | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0210-07 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-210-07) | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0210-12 | 10 BLISTER PACK in 1 CARTON (33342-210-12) / 10 TABLET, EXT... | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0211-07 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-211-07) | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0211-12 | 10 BLISTER PACK in 1 CARTON (33342-211-12) / 10 TABLET, EXT... | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0212-07 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-212-07) | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0212-12 | 10 BLISTER PACK in 1 CARTON (33342-212-12) / 10 TABLET, EXT... | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0213-07 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-213-07) | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0213-12 | 10 BLISTER PACK in 1 CARTON (33342-213-12) / 10 TABLET, EXT... | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0214-07 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-214-07) | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 33342-0214-12 | 10 BLISTER PACK in 1 CARTON (33342-214-12) / 10 TABLET, EXT... | Pramipexole Dihydrochloride | Macleods Pharmaceuticals Limited | 2020-08-24 |
| 46708-0574-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-574-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Limited | 2019-01-03 |
| 46708-0575-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-575-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Limited | 2019-01-03 |
| 46708-0576-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-576-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Limited | 2019-01-03 |
| 46708-0577-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-577-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Limited | 2019-01-03 |
| 46708-0578-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-578-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Limited | 2019-01-03 |
| 46708-0579-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-579-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Limited | 2019-01-03 |
| 46708-0580-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-580-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Limited | 2019-01-03 |
| 50742-0331-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-331-30) | Pramipexole dihydrochloride | Ingenus Pharmaceuticals, LLC | 2022-03-10 |
| 50742-0332-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-332-30) | Pramipexole dihydrochloride | Ingenus Pharmaceuticals, LLC | 2022-03-10 |
| 50742-0333-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-333-30) | Pramipexole dihydrochloride | Ingenus Pharmaceuticals, LLC | 2022-03-10 |
| 50742-0334-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-334-30) | Pramipexole dihydrochloride | Ingenus Pharmaceuticals, LLC | 2022-03-10 |
| 50742-0335-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-335-30) | Pramipexole dihydrochloride | Ingenus Pharmaceuticals, LLC | 2022-03-10 |
| 50742-0336-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-336-30) | Pramipexole dihydrochloride | Ingenus Pharmaceuticals, LLC | 2022-03-10 |
| 50742-0337-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-337-30) | Pramipexole dihydrochloride | Ingenus Pharmaceuticals, LLC | 2022-03-10 |
| 55111-0611-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-611-30) | Pramipexole dihydrochloride | Dr. Reddy's Laboratories Limited | 2015-08-14 |
| 55111-0612-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-612-30) | Pramipexole dihydrochloride | Dr. Reddy's Laboratories Limited | 2015-08-14 |
| 55111-0613-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-613-30) | Pramipexole dihydrochloride | Dr. Reddy's Laboratories Limited | 2015-08-14 |
| 55111-0614-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-614-30) | Pramipexole dihydrochloride | Dr. Reddy's Laboratories Limited | 2015-08-14 |
| 55111-0615-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-615-30) | Pramipexole dihydrochloride | Dr. Reddy's Laboratories Limited | 2015-08-14 |
| 62332-0154-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-154-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Inc. | 2019-01-03 |
| 62332-0155-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-155-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Inc. | 2019-01-03 |
| 62332-0156-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-156-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Inc. | 2019-01-03 |
| 62332-0157-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-157-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Inc. | 2019-01-03 |
| 62332-0158-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-158-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Inc. | 2019-01-03 |
| 62332-0159-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-159-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Inc. | 2019-01-03 |
| 62332-0160-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-160-30) | Pramipexole Dihydrochloride | Alembic Pharmaceuticals Inc. | 2019-01-03 |
Observed labelers:
Macleods Pharmaceuticals Limited (14) ·
Alembic Pharmaceuticals Inc. (7) ·
Alembic Pharmaceuticals Limited (7) ·
Ingenus Pharmaceuticals, LLC (7) ·
NorthStar RxLLC (6) ·
Dr. Reddy's Laboratories Limited (5)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.